Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
作者信息
Gubatan John, Levitte Steven, Patel Akshar, Balabanis Tatiana, Sharma Arpita, Jones Elaina, Lee Bomi, Manohar Murli, Swaminathan Gayathri, Park Walter, Habtezion Aida
机构信息
Divison of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA
Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
出版信息
Gut. 2021 Feb;70(2):440-441. doi: 10.1136/gutjnl-2020-321772. Epub 2020 Jun 3.
Abstract
摘要
相似文献
1
Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.北加利福尼亚州有胰腺炎病史患者中新冠病毒病的患病率、危险因素及临床结局
Gut. 2021 Feb;70(2):440-441. doi: 10.1136/gutjnl-2020-321772. Epub 2020 Jun 3.
2
Pancreatitis in Pediatric Patients With COVID-19.新冠病毒感染患儿的胰腺炎
J Pediatric Infect Dis Soc. 2021 Feb 13;10(1):57-59. doi: 10.1093/jpids/piaa125.
3
Acute pancreatitis in a patient with COVID-19.伴有 COVID-19 的急性胰腺炎。
BMJ Case Rep. 2021 Feb 11;14(2):e239656. doi: 10.1136/bcr-2020-239656.
4
SARS-CoV-2 and acute pancreatitis: a new etiological agent?SARS-CoV-2 与急性胰腺炎：新的病因？
Rev Esp Enferm Dig. 2020 Nov;112(11):890. doi: 10.17235/reed.2020.7481/2020.
5
Clinical Outcomes of Acute Pancreatitis in Patients With Coronavirus Disease 2019.2019冠状病毒病患者急性胰腺炎的临床结局
Gastroenterology. 2020 Nov;159(5):1972-1974. doi: 10.1053/j.gastro.2020.07.038. Epub 2020 Jul 25.
6
The Rising Prevalence of SARS-CoV-2 Infection May Not be Due to Young Adults.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染率的上升可能并非源于年轻人。
Pediatr Infect Dis J. 2021 May 1;40(5):e213-e214. doi: 10.1097/INF.0000000000003097.
7
Coronavirus disease-19 (COVID-19) associated with acute pancreatitis: case report.新型冠状病毒肺炎（COVID-19）相关急性胰腺炎：病例报告。
Pan Afr Med J. 2020 Oct 13;37:150. doi: 10.11604/pamj.2020.37.150.25873. eCollection 2020.
8
Pancreatic involvement in SARS-CoV-2: case report and living review.新型冠状病毒肺炎的胰腺受累：病例报告及文献综述
J Gastrointestin Liver Dis. 2020 Jun 4;29(2):275-276. doi: 10.15403/jgld-2618.
9
SARS-CoV-2 and COVID-19 for the ophthalmologist.眼科医生须知的 SARS-CoV-2 和 COVID-19
Clin Exp Ophthalmol. 2021 Jan;49(1):70-80. doi: 10.1111/ceo.13877. Epub 2020 Nov 9.
10
Essential surgery during the covid 19 pandemic: The implementation of a pre-operative universal covid testing program.新冠疫情期间的必要手术：术前通用新冠检测项目的实施
Am J Surg. 2021 Apr;221(4):770-771. doi: 10.1016/j.amjsurg.2020.08.033. Epub 2020 Aug 31.
引用本文的文献
1
Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients.COVID-19 对有和无预先存在的消化系统疾病的个体的影响，特别关注老年患者。
World J Gastroenterol. 2023 Jul 14;29(26):4099-4119. doi: 10.3748/wjg.v29.i26.4099.
2
Acute pancreatitis and COVID-19: an integrative review of the literature.急性胰腺炎与 COVID-19：文献综合述评。
Rev Col Bras Cir. 2023 Jul 10;50:e20233559. doi: 10.1590/0100-6991e-20233559-en. eCollection 2023.
3
Acute pancreatitis and COVID-19: a new target for infection?急性胰腺炎与 COVID-19：感染的新靶点？
Einstein (Sao Paulo). 2022 Feb 21;20:eRW6667. doi: 10.31744/einstein_journal/2022RW6667. eCollection 2022.
4
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.加拿大克罗恩病与结肠炎协会《2021年新冠疫情对加拿大炎症性肠病的影响：执行摘要》
J Can Assoc Gastroenterol. 2021 Nov 5;4(Suppl 2):S1-S9. doi: 10.1093/jcag/gwab027. eCollection 2021 Dec.
5
Acute Pancreatitis and COVID-19: A Single-Center Experience.急性胰腺炎与新型冠状病毒肺炎：单中心经验
J Multidiscip Healthc. 2021 Oct 9;14:2857-2861. doi: 10.2147/JMDH.S334835. eCollection 2021.
6
Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic.在 COVID-19 大流行期间，功能性胃肠和动力障碍患者的胃肠道症状和医疗保健利用增加。
Neurogastroenterol Motil. 2022 Apr;34(4):e14243. doi: 10.1111/nmo.14243. Epub 2021 Aug 11.
7
Association between acute pancreatitis and COVID-19 infection: What do we know?急性胰腺炎与新型冠状病毒肺炎感染之间的关联：我们了解些什么？
World J Gastrointest Surg. 2021 Jun 27;13(6):548-562. doi: 10.4240/wjgs.v13.i6.548.
8
COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London.东伦敦单中心横断面研究：肝胆胰疾病患者中的 COVID-19。
BMJ Open. 2021 Apr 19;11(4):e045077. doi: 10.1136/bmjopen-2020-045077.
9
Understanding Demographic Risk Factors for Adverse Outcomes in COVID-19 Patients: Explanation of a Deep Learning Model.了解新冠病毒肺炎患者不良结局的人口统计学风险因素：深度学习模型解析
J Healthc Inform Res. 2021;5(2):181-200. doi: 10.1007/s41666-021-00093-9. Epub 2021 Feb 27.
10
SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.严重急性呼吸综合征冠状病毒 2 感染与胰腺炎严重程度和 30 天病死率的相关性：COVID PAN 协作研究
Gut. 2021 Jun;70(6):1061-1069. doi: 10.1136/gutjnl-2020-323364. Epub 2021 Feb 5.
本文引用的文献
1
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
2
Lipase Elevation in Patients With COVID-19.COVID-19 患者的脂肪酶升高。
Am J Gastroenterol. 2020 Aug;115(8):1286-1288. doi: 10.14309/ajg.0000000000000732.
3
Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members.新型冠状病毒病（COVID-19）相关的重症胰腺炎：一家三口发病病例报告。
Pancreatology. 2020 Jun;20(4):665-667. doi: 10.1016/j.pan.2020.04.021. Epub 2020 May 5.
4
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.ACE2 在胰腺中的表达可能导致 SARS-CoV-2 感染后的胰腺损伤。
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2128-2130.e2. doi: 10.1016/j.cgh.2020.04.040. Epub 2020 Apr 22.
Zotero 插件